Tim Schlidt

Tim Schlidt is a co-founder and partner at Palo Santo. Currently, Tim serves as a board member at Ksana Health, Gilgamesh Pharmaceuticals, and Kanna Health. Additionally, Tim is a board observer at Bexson Biomedical and Tactogen. Tim also worked as a private equity associate at Madison Dearborn Partners, LLC, and as an investment banking analyst at Greenhill & Co. Their educational background includes a Bachelor of Business Administration (BBA) in Finance, Investment & Banking from the University of Wisconsin-Madison.